

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.25875129 |
| 2 | protein K11-linked deubiquitination (GO:0035871) | 3.89753561 |
| 3 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.84195420 |
| 4 | protein localization to Golgi apparatus (GO:0034067) | 3.48901555 |
| 5 | Golgi to endosome transport (GO:0006895) | 3.46711516 |
| 6 | locomotory exploration behavior (GO:0035641) | 3.41052611 |
| 7 | phospholipid translocation (GO:0045332) | 3.36020526 |
| 8 | lipid translocation (GO:0034204) | 3.36020526 |
| 9 | negative regulation of complement activation (GO:0045916) | 3.34463545 |
| 10 | neural tube formation (GO:0001841) | 3.32099773 |
| 11 | iron ion import (GO:0097286) | 3.18359870 |
| 12 | nuclear pore complex assembly (GO:0051292) | 3.12361866 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.07254658 |
| 14 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.06590079 |
| 15 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.06180740 |
| 16 | regulation of establishment of cell polarity (GO:2000114) | 3.03969903 |
| 17 | regulation of pigment cell differentiation (GO:0050932) | 3.03435650 |
| 18 | synaptic vesicle maturation (GO:0016188) | 3.03289221 |
| 19 | negative regulation of protein activation cascade (GO:2000258) | 2.99472796 |
| 20 | genitalia morphogenesis (GO:0035112) | 2.96260283 |
| 21 | protein targeting to lysosome (GO:0006622) | 2.95494621 |
| 22 | establishment of protein localization to vacuole (GO:0072666) | 2.95494621 |
| 23 | protein targeting to vacuole (GO:0006623) | 2.95494621 |
| 24 | early endosome to late endosome transport (GO:0045022) | 2.89721525 |
| 25 | cell wall macromolecule catabolic process (GO:0016998) | 2.87869499 |
| 26 | glomerular visceral epithelial cell development (GO:0072015) | 2.87526028 |
| 27 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.85906091 |
| 28 | cellular potassium ion homeostasis (GO:0030007) | 2.85728282 |
| 29 | protein K48-linked deubiquitination (GO:0071108) | 2.85014050 |
| 30 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.84007369 |
| 31 | nucleus localization (GO:0051647) | 2.82088748 |
| 32 | regulation of relaxation of muscle (GO:1901077) | 2.78809118 |
| 33 | glutamate secretion (GO:0014047) | 2.76979218 |
| 34 | sodium ion export (GO:0071436) | 2.74811460 |
| 35 | activation of protein kinase A activity (GO:0034199) | 2.73041200 |
| 36 | regulation of protein glycosylation (GO:0060049) | 2.72824537 |
| 37 | prostate gland growth (GO:0060736) | 2.69457479 |
| 38 | proline transport (GO:0015824) | 2.68151259 |
| 39 | nuclear pore organization (GO:0006999) | 2.68057837 |
| 40 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.66421683 |
| 41 | prenylation (GO:0097354) | 2.66373825 |
| 42 | protein prenylation (GO:0018342) | 2.66373825 |
| 43 | regulation of ARF protein signal transduction (GO:0032012) | 2.63506097 |
| 44 | histone mRNA catabolic process (GO:0071044) | 2.61599844 |
| 45 | negative regulation of neurotransmitter transport (GO:0051589) | 2.61557408 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.61007415 |
| 47 | negative regulation of sodium ion transport (GO:0010766) | 2.60949415 |
| 48 | microtubule anchoring (GO:0034453) | 2.58611573 |
| 49 | protein localization to endosome (GO:0036010) | 2.57872355 |
| 50 | regulation of Rac protein signal transduction (GO:0035020) | 2.56708308 |
| 51 | cell wall macromolecule metabolic process (GO:0044036) | 2.55911191 |
| 52 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.55063189 |
| 53 | glomerular epithelial cell development (GO:0072310) | 2.54999818 |
| 54 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.53653015 |
| 55 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.53041396 |
| 56 | myelin assembly (GO:0032288) | 2.52892678 |
| 57 | protein targeting to Golgi (GO:0000042) | 2.52268236 |
| 58 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.50363310 |
| 59 | regulation of hexokinase activity (GO:1903299) | 2.50030846 |
| 60 | regulation of glucokinase activity (GO:0033131) | 2.50030846 |
| 61 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.45551760 |
| 62 | interkinetic nuclear migration (GO:0022027) | 2.45053386 |
| 63 | macroautophagy (GO:0016236) | 2.44714784 |
| 64 | vocalization behavior (GO:0071625) | 2.44304694 |
| 65 | establishment of protein localization to Golgi (GO:0072600) | 2.41847649 |
| 66 | regulation of centriole replication (GO:0046599) | 2.41115952 |
| 67 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.40119794 |
| 68 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.39891702 |
| 69 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.39083458 |
| 70 | potassium ion import (GO:0010107) | 2.39032315 |
| 71 | dorsal/ventral axis specification (GO:0009950) | 2.37659561 |
| 72 | establishment of nucleus localization (GO:0040023) | 2.37018315 |
| 73 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.36670215 |
| 74 | vesicle transport along microtubule (GO:0047496) | 2.36349479 |
| 75 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.35238819 |
| 76 | fibroblast migration (GO:0010761) | 2.34821912 |
| 77 | dendrite morphogenesis (GO:0048813) | 2.34774447 |
| 78 | central nervous system neuron axonogenesis (GO:0021955) | 2.33710904 |
| 79 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.33305254 |
| 80 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.33305254 |
| 81 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.33305254 |
| 82 | layer formation in cerebral cortex (GO:0021819) | 2.33267579 |
| 83 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.32849779 |
| 84 | regulation of synapse structural plasticity (GO:0051823) | 2.31269289 |
| 85 | fatty acid transmembrane transport (GO:1902001) | 2.31239901 |
| 86 | nerve growth factor signaling pathway (GO:0038180) | 2.30636835 |
| 87 | synaptic vesicle exocytosis (GO:0016079) | 2.30359275 |
| 88 | pericardium development (GO:0060039) | 2.29484273 |
| 89 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.29456442 |
| 90 | innervation (GO:0060384) | 2.29007856 |
| 91 | positive regulation of vascular permeability (GO:0043117) | 2.28654700 |
| 92 | carnitine shuttle (GO:0006853) | 2.27323009 |
| 93 | negative regulation of humoral immune response (GO:0002921) | 2.26561593 |
| 94 | regulation of protein polyubiquitination (GO:1902914) | 2.26344814 |
| 95 | regulation of cell communication by electrical coupling (GO:0010649) | 2.26324271 |
| 96 | relaxation of cardiac muscle (GO:0055119) | 2.25581857 |
| 97 | cellular response to sterol (GO:0036315) | 2.25283850 |
| 98 | alpha-linolenic acid metabolic process (GO:0036109) | 2.25164317 |
| 99 | cyclic nucleotide catabolic process (GO:0009214) | 2.25054994 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.24788880 |
| 101 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.24765314 |
| 102 | exploration behavior (GO:0035640) | 2.24414750 |
| 103 | NLS-bearing protein import into nucleus (GO:0006607) | 2.22477453 |
| 104 | growth hormone receptor signaling pathway (GO:0060396) | 2.22310163 |
| 105 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.21903618 |
| 106 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.21873204 |
| 107 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.21673613 |
| 108 | cell communication by electrical coupling (GO:0010644) | 2.21516326 |
| 109 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.21174397 |
| 110 | positive regulation of muscle hypertrophy (GO:0014742) | 2.21096178 |
| 111 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.21096178 |
| 112 | regulation of energy homeostasis (GO:2000505) | 2.20736346 |
| 113 | positive regulation of protein autophosphorylation (GO:0031954) | 2.20499620 |
| 114 | mitotic sister chromatid cohesion (GO:0007064) | 2.20277392 |
| 115 | regulation of synaptic vesicle transport (GO:1902803) | 2.19951012 |
| 116 | acrosome assembly (GO:0001675) | 2.18955877 |
| 117 | response to lipoprotein particle (GO:0055094) | 2.18640975 |
| 118 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.17284758 |
| 119 | plasma membrane repair (GO:0001778) | 2.16827206 |
| 120 | protein K63-linked deubiquitination (GO:0070536) | 2.16708068 |
| 121 | positive regulation of Rab GTPase activity (GO:0032851) | 2.16402377 |
| 122 | regulation of Rab GTPase activity (GO:0032313) | 2.16402377 |
| 123 | alanine transport (GO:0032328) | 2.14082436 |
| 124 | cAMP catabolic process (GO:0006198) | 2.13975307 |
| 125 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.13690945 |
| 126 | pore complex assembly (GO:0046931) | 2.13559834 |
| 127 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.13516342 |
| 128 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.13030252 |
| 129 | cellular sodium ion homeostasis (GO:0006883) | 2.12960287 |
| 130 | COPII vesicle coating (GO:0048208) | 2.12841835 |
| 131 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.12309995 |
| 132 | neuronal action potential propagation (GO:0019227) | 2.11645567 |
| 133 | acrosome reaction (GO:0007340) | 2.10268390 |
| 134 | cell communication involved in cardiac conduction (GO:0086065) | 2.10123172 |
| 135 | cellular ketone body metabolic process (GO:0046950) | 2.09181057 |
| 136 | phospholipid homeostasis (GO:0055091) | 2.07156209 |
| 137 | neurotransmitter secretion (GO:0007269) | 2.03386531 |
| 138 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.03285602 |
| 139 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.03201071 |
| 140 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.03185457 |
| 141 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.01351324 |
| 142 | clathrin coat assembly (GO:0048268) | 2.00104472 |
| 143 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 1.97999112 |
| 144 | positive regulation of glycolytic process (GO:0045821) | 1.97155015 |
| 145 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 1.96253721 |
| 146 | cerebellar Purkinje cell differentiation (GO:0021702) | 1.94690253 |
| 147 | gamma-aminobutyric acid transport (GO:0015812) | 1.94286432 |
| 148 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 1.94110115 |
| 149 | L-phenylalanine catabolic process (GO:0006559) | 1.94110115 |
| 150 | intracellular lipid transport (GO:0032365) | 1.93977132 |
| 151 | apoptotic cell clearance (GO:0043277) | 1.91970594 |
| 152 | neuromuscular process controlling balance (GO:0050885) | 1.91895211 |
| 153 | endoplasmic reticulum organization (GO:0007029) | 1.91614889 |
| 154 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 1.91557400 |
| 155 | long-term synaptic potentiation (GO:0060291) | 1.91374298 |
| 156 | membrane repolarization during action potential (GO:0086011) | 1.90837048 |
| 157 | lysine metabolic process (GO:0006553) | 1.89874982 |
| 158 | lysine catabolic process (GO:0006554) | 1.89874982 |
| 159 | regulation of glutamate receptor signaling pathway (GO:1900449) | 1.89370904 |
| 160 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 1.89157709 |
| 161 | positive regulation of potassium ion transport (GO:0043268) | 1.88007662 |
| 162 | ketone body metabolic process (GO:1902224) | 1.87422922 |
| 163 | stress fiber assembly (GO:0043149) | 1.86898178 |
| 164 | membrane repolarization (GO:0086009) | 1.86828671 |
| 165 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 1.86165284 |
| 166 | long-term memory (GO:0007616) | 1.86107286 |
| 167 | glutamate receptor signaling pathway (GO:0007215) | 1.85535023 |
| 168 | positive regulation of axon extension (GO:0045773) | 1.84772361 |
| 169 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.84613170 |
| 170 | regulation of dendritic spine morphogenesis (GO:0061001) | 1.83941474 |
| 171 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.83621015 |
| 172 | cellular response to ethanol (GO:0071361) | 1.83577662 |
| 173 | organelle transport along microtubule (GO:0072384) | 1.83113505 |
| 174 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 1.83033773 |
| 175 | neurotransmitter-gated ion channel clustering (GO:0072578) | 1.82702671 |
| 176 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 1.81381993 |
| 177 | cerebellar granule cell differentiation (GO:0021707) | 1.80693900 |
| 178 | potassium ion homeostasis (GO:0055075) | 1.80567748 |
| 179 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.80540251 |
| 180 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 1.80146622 |
| 181 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 1.80058211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.04420981 |
| 2 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.45277155 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.33991977 |
| 4 | FUS_26573619_Chip-Seq_HEK293_Human | 2.16483162 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.15126268 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.13994700 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11852862 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96269769 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.96096853 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83386222 |
| 11 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83274055 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80702770 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79531695 |
| 14 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.77268279 |
| 15 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.76969816 |
| 16 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.74802939 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.73333514 |
| 18 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.69519237 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68520529 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.65469078 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.64501013 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.64034889 |
| 23 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.62937794 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60528295 |
| 25 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.60206399 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59897202 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59255091 |
| 28 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.58952326 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.58335115 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.57741163 |
| 31 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.57485145 |
| 32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.57337490 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57008038 |
| 34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55775600 |
| 35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55683886 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55683886 |
| 37 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.54258756 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.54122791 |
| 39 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.54122791 |
| 40 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.53861211 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.53191903 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51932419 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51618632 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51082480 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.50124094 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48022412 |
| 47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.45764312 |
| 48 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.45261612 |
| 49 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44427710 |
| 50 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42708347 |
| 51 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42708347 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42522583 |
| 53 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42472924 |
| 54 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.41811928 |
| 55 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.41718907 |
| 56 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40479466 |
| 57 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.40284925 |
| 58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.39550829 |
| 59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38537241 |
| 60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38135749 |
| 61 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.37806663 |
| 62 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.37326839 |
| 63 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36285389 |
| 64 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.34726062 |
| 65 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32026246 |
| 66 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.30894358 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30488551 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28575333 |
| 69 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.28561700 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28121479 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28121479 |
| 72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26908140 |
| 73 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.26875901 |
| 74 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25143119 |
| 75 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24605079 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24017108 |
| 77 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23350775 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23191033 |
| 79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23089096 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22944446 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21742400 |
| 82 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21561039 |
| 83 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21373211 |
| 84 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.21015714 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21003076 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20869244 |
| 87 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20639718 |
| 88 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19653093 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19627298 |
| 90 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19379395 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.18237560 |
| 92 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.18114267 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17342186 |
| 94 | KDM2B_26808549_Chip-Seq_REH_Human | 1.17232493 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17034455 |
| 96 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.16015116 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15357054 |
| 98 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.15249552 |
| 99 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13823712 |
| 100 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13044942 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.12642101 |
| 102 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.12052751 |
| 103 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11458664 |
| 104 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11292664 |
| 105 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11260479 |
| 106 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10863560 |
| 107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10748312 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10604513 |
| 109 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.10580711 |
| 110 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.10159623 |
| 111 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.09159627 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09039139 |
| 113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08807826 |
| 114 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08620094 |
| 115 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07216611 |
| 116 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07193826 |
| 117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07109114 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05449180 |
| 119 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05022977 |
| 120 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04734570 |
| 121 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04155828 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03782631 |
| 123 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03539541 |
| 124 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.03249428 |
| 125 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02316739 |
| 126 | * AR_19668381_ChIP-Seq_PC3_Human | 1.01974675 |
| 127 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01714014 |
| 128 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01230652 |
| 129 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00855726 |
| 130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00226439 |
| 131 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99060720 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98275337 |
| 133 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98222603 |
| 134 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.98142877 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97663276 |
| 136 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96513386 |
| 137 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96163181 |
| 138 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94586892 |
| 139 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.93918930 |
| 140 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91737662 |
| 141 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91364393 |
| 142 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91226242 |
| 143 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90974659 |
| 144 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89253716 |
| 145 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.89105102 |
| 146 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88989337 |
| 147 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87912978 |
| 148 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87761263 |
| 149 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86954591 |
| 150 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85418159 |
| 151 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83654263 |
| 152 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83654263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.39352209 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.65334058 |
| 3 | MP0010678_abnormal_skin_adnexa | 3.04800295 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 2.91576218 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.72632348 |
| 6 | MP0000427_abnormal_hair_cycle | 2.71941507 |
| 7 | MP0000383_abnormal_hair_follicle | 2.68909978 |
| 8 | MP0005248_abnormal_Harderian_gland | 2.61259819 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.60584240 |
| 10 | MP0002009_preneoplasia | 2.36563669 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.27611400 |
| 12 | MP0004130_abnormal_muscle_cell | 2.26620149 |
| 13 | MP0004270_analgesia | 2.26272187 |
| 14 | MP0005360_urolithiasis | 2.26058620 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.13852573 |
| 16 | MP0003252_abnormal_bile_duct | 2.12670838 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.12098985 |
| 18 | MP0003635_abnormal_synaptic_transmissio | 2.09470599 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.05272842 |
| 20 | MP0004858_abnormal_nervous_system | 2.05139774 |
| 21 | MP0005365_abnormal_bile_salt | 2.01103935 |
| 22 | MP0003690_abnormal_glial_cell | 1.99574502 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.97591524 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.97442404 |
| 25 | MP0002102_abnormal_ear_morphology | 1.95528417 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.88721554 |
| 27 | MP0003646_muscle_fatigue | 1.86889589 |
| 28 | MP0003329_amyloid_beta_deposits | 1.80372981 |
| 29 | MP0005408_hypopigmentation | 1.77781446 |
| 30 | MP0001984_abnormal_olfaction | 1.77579058 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.74247180 |
| 32 | MP0009697_abnormal_copulation | 1.74043388 |
| 33 | MP0006054_spinal_hemorrhage | 1.72589142 |
| 34 | MP0003890_abnormal_embryonic-extraembry | 1.67959642 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.67456158 |
| 36 | MP0000604_amyloidosis | 1.64470986 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.60391561 |
| 38 | MP0004145_abnormal_muscle_electrophysio | 1.60116526 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.58998084 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.58766361 |
| 41 | MP0000751_myopathy | 1.53880809 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.53822634 |
| 43 | MP0009745_abnormal_behavioral_response | 1.52031619 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.51757831 |
| 45 | MP0000747_muscle_weakness | 1.49373934 |
| 46 | MP0002064_seizures | 1.47930744 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.46954498 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.46365389 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.42323562 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.41956822 |
| 51 | MP0003195_calcinosis | 1.41824579 |
| 52 | MP0009046_muscle_twitch | 1.39909598 |
| 53 | MP0008438_abnormal_cutaneous_collagen | 1.39627578 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.38265276 |
| 55 | MP0005367_renal/urinary_system_phenotyp | 1.37487462 |
| 56 | MP0000516_abnormal_urinary_system | 1.37487462 |
| 57 | MP0005167_abnormal_blood-brain_barrier | 1.36542198 |
| 58 | MP0003075_altered_response_to | 1.35537244 |
| 59 | MP0003303_peritoneal_inflammation | 1.35468847 |
| 60 | MP0003045_fibrosis | 1.34104388 |
| 61 | MP0003633_abnormal_nervous_system | 1.30920756 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.30596332 |
| 63 | MP0004043_abnormal_pH_regulation | 1.29005142 |
| 64 | MP0005253_abnormal_eye_physiology | 1.25627469 |
| 65 | MP0000920_abnormal_myelination | 1.25048117 |
| 66 | MP0008877_abnormal_DNA_methylation | 1.24959636 |
| 67 | MP0005409_darkened_coat_color | 1.22302567 |
| 68 | MP0005410_abnormal_fertilization | 1.20847729 |
| 69 | MP0001661_extended_life_span | 1.20152344 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 1.20041643 |
| 71 | MP0000749_muscle_degeneration | 1.19808055 |
| 72 | MP0003941_abnormal_skin_development | 1.18766384 |
| 73 | MP0001299_abnormal_eye_distance/ | 1.18037551 |
| 74 | MP0001958_emphysema | 1.17906516 |
| 75 | MP0004215_abnormal_myocardial_fiber | 1.17395387 |
| 76 | MP0004510_myositis | 1.17176581 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 1.14927470 |
| 78 | MP0003787_abnormal_imprinting | 1.13656938 |
| 79 | MP0003937_abnormal_limbs/digits/tail_de | 1.13092299 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.12596402 |
| 81 | MP0004084_abnormal_cardiac_muscle | 1.12526789 |
| 82 | MP0002734_abnormal_mechanical_nocicepti | 1.12439410 |
| 83 | MP0001486_abnormal_startle_reflex | 1.10744503 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 1.10283051 |
| 85 | MP0001968_abnormal_touch/_nociception | 1.10024030 |
| 86 | MP0004087_abnormal_muscle_fiber | 1.08133048 |
| 87 | MP0010368_abnormal_lymphatic_system | 1.08065941 |
| 88 | MP0004885_abnormal_endolymph | 1.06770888 |
| 89 | MP0004233_abnormal_muscle_weight | 1.06156531 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 1.05871499 |
| 91 | MP0001177_atelectasis | 1.05177092 |
| 92 | MP0005451_abnormal_body_composition | 1.05035493 |
| 93 | MP0000371_diluted_coat_color | 1.04910705 |
| 94 | MP0003632_abnormal_nervous_system | 1.04534423 |
| 95 | MP0001440_abnormal_grooming_behavior | 1.03770653 |
| 96 | MP0002166_altered_tumor_susceptibility | 1.03169090 |
| 97 | MP0005171_absent_coat_pigmentation | 1.02324931 |
| 98 | MP0002090_abnormal_vision | 1.02139985 |
| 99 | MP0002272_abnormal_nervous_system | 1.01941713 |
| 100 | MP0009384_cardiac_valve_regurgitation | 1.01373372 |
| 101 | MP0005620_abnormal_muscle_contractility | 1.01091232 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 1.00448719 |
| 103 | MP0005332_abnormal_amino_acid | 0.99891609 |
| 104 | MP0005535_abnormal_body_temperature | 0.99006741 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.97886813 |
| 106 | MP0002067_abnormal_sensory_capabilities | 0.97880367 |
| 107 | MP0004484_altered_response_of | 0.97599863 |
| 108 | MP0003868_abnormal_feces_composition | 0.97251043 |
| 109 | MP0002108_abnormal_muscle_morphology | 0.97118753 |
| 110 | MP0003631_nervous_system_phenotype | 0.95668821 |
| 111 | MP0003634_abnormal_glial_cell | 0.95505867 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.94612090 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.94548511 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.93911867 |
| 115 | MP0002971_abnormal_brown_adipose | 0.93392885 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.93162694 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.92563316 |
| 118 | MP0008569_lethality_at_weaning | 0.92380309 |
| 119 | MP0010307_abnormal_tumor_latency | 0.92091277 |
| 120 | MP0005083_abnormal_biliary_tract | 0.90334262 |
| 121 | MP0000647_abnormal_sebaceous_gland | 0.90328435 |
| 122 | MP0001501_abnormal_sleep_pattern | 0.90269301 |
| 123 | MP0005275_abnormal_skin_tensile | 0.89563936 |
| 124 | MP0008961_abnormal_basal_metabolism | 0.88941942 |
| 125 | MP0002733_abnormal_thermal_nociception | 0.87892773 |
| 126 | MP0005187_abnormal_penis_morphology | 0.87731949 |
| 127 | MP0000003_abnormal_adipose_tissue | 0.87536129 |
| 128 | MP0005386_behavior/neurological_phenoty | 0.87127631 |
| 129 | MP0004924_abnormal_behavior | 0.87127631 |
| 130 | MP0005310_abnormal_salivary_gland | 0.86964061 |
| 131 | MP0002168_other_aberrant_phenotype | 0.86376823 |
| 132 | MP0004085_abnormal_heartbeat | 0.86215961 |
| 133 | MP0005647_abnormal_sex_gland | 0.85888560 |
| 134 | MP0002269_muscular_atrophy | 0.85336020 |
| 135 | MP0002972_abnormal_cardiac_muscle | 0.84883531 |
| 136 | MP0004134_abnormal_chest_morphology | 0.84570025 |
| 137 | MP0002006_tumorigenesis | 0.83925116 |
| 138 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83125170 |
| 139 | MP0009840_abnormal_foam_cell | 0.82756197 |
| 140 | MP0003091_abnormal_cell_migration | 0.82281663 |
| 141 | MP0005166_decreased_susceptibility_to | 0.81956160 |
| 142 | MP0002078_abnormal_glucose_homeostasis | 0.81459742 |
| 143 | MP0005395_other_phenotype | 0.80332744 |
| 144 | MP0001485_abnormal_pinna_reflex | 0.80257728 |
| 145 | MP0008874_decreased_physiological_sensi | 0.79965011 |
| 146 | MP0005375_adipose_tissue_phenotype | 0.79790874 |
| 147 | MP0004272_abnormal_basement_membrane | 0.79373790 |
| 148 | MP0001879_abnormal_lymphatic_vessel | 0.78188376 |
| 149 | MP0003935_abnormal_craniofacial_develop | 0.77655877 |
| 150 | MP0002928_abnormal_bile_duct | 0.74935941 |
| 151 | MP0009115_abnormal_fat_cell | 0.74794924 |
| 152 | MP0000428_abnormal_craniofacial_morphol | 0.73742939 |
| 153 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71102347 |
| 154 | MP0002638_abnormal_pupillary_reflex | 0.70651264 |
| 155 | MP0010386_abnormal_urinary_bladder | 0.69732096 |
| 156 | MP0005220_abnormal_exocrine_pancreas | 0.68515138 |
| 157 | MP0005266_abnormal_metabolism | 0.67200163 |
| 158 | MP0009703_decreased_birth_body | 0.65691664 |
| 159 | MP0001324_abnormal_eye_pigmentation | 0.65253393 |
| 160 | MP0000432_abnormal_head_morphology | 0.64094845 |
| 161 | MP0004883_abnormal_blood_vessel | 0.63067378 |
| 162 | MP0002127_abnormal_cardiovascular_syste | 0.62460681 |
| 163 | MP0003828_pulmonary_edema | 0.61936659 |
| 164 | MP0002233_abnormal_nose_morphology | 0.61691461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 4.36849911 |
| 2 | Action tremor (HP:0002345) | 3.28728202 |
| 3 | Tubulointerstitial nephritis (HP:0001970) | 3.12804150 |
| 4 | Thyroid carcinoma (HP:0002890) | 3.03568348 |
| 5 | Chronic hepatic failure (HP:0100626) | 3.03491931 |
| 6 | Fair hair (HP:0002286) | 2.95845548 |
| 7 | Deep venous thrombosis (HP:0002625) | 2.82487626 |
| 8 | Gaze-evoked nystagmus (HP:0000640) | 2.82277257 |
| 9 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.76947270 |
| 10 | Subaortic stenosis (HP:0001682) | 2.76947270 |
| 11 | Focal motor seizures (HP:0011153) | 2.64162680 |
| 12 | Exercise-induced myalgia (HP:0003738) | 2.61090565 |
| 13 | Neurofibrillary tangles (HP:0002185) | 2.59530630 |
| 14 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.56413314 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 2.48696071 |
| 16 | Curly hair (HP:0002212) | 2.48381970 |
| 17 | Insidious onset (HP:0003587) | 2.47928087 |
| 18 | Termporal pattern (HP:0011008) | 2.47928087 |
| 19 | Hypoplastic labia majora (HP:0000059) | 2.47677775 |
| 20 | Focal seizures (HP:0007359) | 2.46188612 |
| 21 | Visual hallucinations (HP:0002367) | 2.46044190 |
| 22 | Complement deficiency (HP:0004431) | 2.44644667 |
| 23 | Intention tremor (HP:0002080) | 2.40313720 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 2.39753168 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 2.37076971 |
| 26 | Ketoacidosis (HP:0001993) | 2.36457351 |
| 27 | Abnormality of the labia majora (HP:0012881) | 2.36157622 |
| 28 | Arterial tortuosity (HP:0005116) | 2.35846781 |
| 29 | Generalized hypopigmentation of hair (HP:0011358) | 2.32237891 |
| 30 | Widely spaced teeth (HP:0000687) | 2.27114833 |
| 31 | Cerebral aneurysm (HP:0004944) | 2.26125905 |
| 32 | Retinal atrophy (HP:0001105) | 2.25685590 |
| 33 | Vascular tortuosity (HP:0004948) | 2.24069050 |
| 34 | Myokymia (HP:0002411) | 2.20959846 |
| 35 | Pancreatic cysts (HP:0001737) | 2.20897673 |
| 36 | Pancreatic fibrosis (HP:0100732) | 2.18851470 |
| 37 | Postural instability (HP:0002172) | 2.16848944 |
| 38 | Macroorchidism (HP:0000053) | 2.15882969 |
| 39 | Aqueductal stenosis (HP:0002410) | 2.15666698 |
| 40 | Atonic seizures (HP:0010819) | 2.15594742 |
| 41 | Truncal obesity (HP:0001956) | 2.15311940 |
| 42 | Abnormal biliary tract morphology (HP:0012440) | 2.15309520 |
| 43 | Overgrowth (HP:0001548) | 2.15148342 |
| 44 | Cystic hygroma (HP:0000476) | 2.14004938 |
| 45 | Biliary tract neoplasm (HP:0100574) | 2.13368350 |
| 46 | Abnormality of the renal cortex (HP:0011035) | 2.13139537 |
| 47 | Long clavicles (HP:0000890) | 2.08314073 |
| 48 | Exercise-induced muscle cramps (HP:0003710) | 2.06943138 |
| 49 | Febrile seizures (HP:0002373) | 2.06352966 |
| 50 | Mitral stenosis (HP:0001718) | 2.06328261 |
| 51 | Menstrual irregularities (HP:0000858) | 2.04966618 |
| 52 | Thyroiditis (HP:0100646) | 2.03700065 |
| 53 | Dysdiadochokinesis (HP:0002075) | 2.03547635 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.02858686 |
| 55 | Tubulointerstitial abnormality (HP:0001969) | 2.02560934 |
| 56 | Aortic aneurysm (HP:0004942) | 2.01955943 |
| 57 | Xanthomatosis (HP:0000991) | 2.01912484 |
| 58 | Ketosis (HP:0001946) | 1.99293702 |
| 59 | Dysmetric saccades (HP:0000641) | 1.97469185 |
| 60 | Large earlobe (HP:0009748) | 1.96990923 |
| 61 | Difficulty running (HP:0009046) | 1.96301452 |
| 62 | Subacute progressive viral hepatitis (HP:0006572) | 1.95493915 |
| 63 | Progressive cerebellar ataxia (HP:0002073) | 1.95308939 |
| 64 | Epidermoid cyst (HP:0200040) | 1.95185320 |
| 65 | Hamartoma of the eye (HP:0010568) | 1.94808902 |
| 66 | Calf muscle hypertrophy (HP:0008981) | 1.94327618 |
| 67 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.93850028 |
| 68 | Absence seizures (HP:0002121) | 1.93435670 |
| 69 | Volvulus (HP:0002580) | 1.92820603 |
| 70 | Intestinal atresia (HP:0011100) | 1.92395811 |
| 71 | Resting tremor (HP:0002322) | 1.92182795 |
| 72 | Hepatoblastoma (HP:0002884) | 1.90902347 |
| 73 | Central scotoma (HP:0000603) | 1.90715119 |
| 74 | Abnormality of potassium homeostasis (HP:0011042) | 1.90386445 |
| 75 | Hypoalphalipoproteinemia (HP:0003233) | 1.90082639 |
| 76 | Genital tract atresia (HP:0001827) | 1.90058263 |
| 77 | Buphthalmos (HP:0000557) | 1.89907926 |
| 78 | Broad metatarsal (HP:0001783) | 1.89841300 |
| 79 | Scanning speech (HP:0002168) | 1.89487710 |
| 80 | Type 1 muscle fiber predominance (HP:0003803) | 1.88272439 |
| 81 | Dysmetria (HP:0001310) | 1.86653751 |
| 82 | Short tibia (HP:0005736) | 1.86443469 |
| 83 | Ankle clonus (HP:0011448) | 1.86419906 |
| 84 | Absent speech (HP:0001344) | 1.85307122 |
| 85 | Abnormal auditory evoked potentials (HP:0006958) | 1.85243385 |
| 86 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.84861218 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.84668199 |
| 88 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.84522761 |
| 89 | Skin nodule (HP:0200036) | 1.84254146 |
| 90 | Hematochezia (HP:0002573) | 1.83014900 |
| 91 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82170419 |
| 92 | Protuberant abdomen (HP:0001538) | 1.81981806 |
| 93 | Impaired social interactions (HP:0000735) | 1.81887528 |
| 94 | Abnormal social behavior (HP:0012433) | 1.81887528 |
| 95 | Generalized tonic-clonic seizures (HP:0002069) | 1.81217516 |
| 96 | Bundle branch block (HP:0011710) | 1.80614679 |
| 97 | Bladder carcinoma (HP:0002862) | 1.80285718 |
| 98 | Bladder neoplasm (HP:0009725) | 1.80285718 |
| 99 | Frequent falls (HP:0002359) | 1.79593693 |
| 100 | Neuroendocrine neoplasm (HP:0100634) | 1.78782080 |
| 101 | Dysostosis multiplex (HP:0000943) | 1.78697435 |
| 102 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.78613288 |
| 103 | Increased CSF protein (HP:0002922) | 1.78390914 |
| 104 | Decreased lacrimation (HP:0000633) | 1.78242300 |
| 105 | Intrahepatic cholestasis (HP:0001406) | 1.78144825 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 1.77478855 |
| 107 | Depression (HP:0000716) | 1.77312427 |
| 108 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.75412549 |
| 109 | Hip dysplasia (HP:0001385) | 1.75397013 |
| 110 | Hypoplastic ischia (HP:0003175) | 1.75168324 |
| 111 | Excessive salivation (HP:0003781) | 1.74902005 |
| 112 | Drooling (HP:0002307) | 1.74902005 |
| 113 | Tubular atrophy (HP:0000092) | 1.74463262 |
| 114 | Postural tremor (HP:0002174) | 1.74450315 |
| 115 | Sandal gap (HP:0001852) | 1.74234721 |
| 116 | Abnormality of the calf musculature (HP:0001430) | 1.73403122 |
| 117 | Papilledema (HP:0001085) | 1.73389903 |
| 118 | Hyperkalemia (HP:0002153) | 1.73246213 |
| 119 | Hamartoma (HP:0010566) | 1.72754850 |
| 120 | Breast carcinoma (HP:0003002) | 1.72563155 |
| 121 | Mitral valve prolapse (HP:0001634) | 1.72023947 |
| 122 | Hyperglycemia (HP:0003074) | 1.71797199 |
| 123 | Sudden death (HP:0001699) | 1.71517685 |
| 124 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70697977 |
| 125 | Absent/shortened dynein arms (HP:0200106) | 1.70697977 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.70550553 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.70550553 |
| 128 | True hermaphroditism (HP:0010459) | 1.70455971 |
| 129 | Poor coordination (HP:0002370) | 1.70414587 |
| 130 | Cerebellar dysplasia (HP:0007033) | 1.69808724 |
| 131 | Narrow palate (HP:0000189) | 1.69209683 |
| 132 | Pheochromocytoma (HP:0002666) | 1.69180749 |
| 133 | Neoplasm of the small intestine (HP:0100833) | 1.68856885 |
| 134 | Myoglobinuria (HP:0002913) | 1.68012978 |
| 135 | Abnormality of the lower motor neuron (HP:0002366) | 1.67934286 |
| 136 | Blue irides (HP:0000635) | 1.66799922 |
| 137 | Asymmetric septal hypertrophy (HP:0001670) | 1.66615138 |
| 138 | Furrowed tongue (HP:0000221) | 1.66526469 |
| 139 | Ventricular fibrillation (HP:0001663) | 1.66061319 |
| 140 | Abnormality of the ischium (HP:0003174) | 1.65340087 |
| 141 | Turricephaly (HP:0000262) | 1.65263214 |
| 142 | Abnormal ciliary motility (HP:0012262) | 1.64795624 |
| 143 | Hyperventilation (HP:0002883) | 1.64603217 |
| 144 | Cone-rod dystrophy (HP:0000548) | 1.64573014 |
| 145 | Aneurysm (HP:0002617) | 1.64227599 |
| 146 | Status epilepticus (HP:0002133) | 1.63390049 |
| 147 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.63154494 |
| 148 | Scotoma (HP:0000575) | 1.62998563 |
| 149 | Nemaline bodies (HP:0003798) | 1.62739397 |
| 150 | Gout (HP:0001997) | 1.62678048 |
| 151 | Poor eye contact (HP:0000817) | 1.62646249 |
| 152 | Focal segmental glomerulosclerosis (HP:0000097) | 1.61936263 |
| 153 | Syncope (HP:0001279) | 1.61721460 |
| 154 | Abnormality of the intrinsic pathway (HP:0010989) | 1.61300898 |
| 155 | Muscle fiber inclusion bodies (HP:0100299) | 1.61194975 |
| 156 | Vaginal atresia (HP:0000148) | 1.61184863 |
| 157 | Abnormality of the common coagulation pathway (HP:0010990) | 1.60857468 |
| 158 | Increased cerebral lipofuscin (HP:0011813) | 1.60526429 |
| 159 | Increased variability in muscle fiber diameter (HP:0003557) | 1.60427250 |
| 160 | Dialeptic seizures (HP:0011146) | 1.60258242 |
| 161 | Glomerulonephritis (HP:0000099) | 1.60004191 |
| 162 | Abnormality of the renal medulla (HP:0100957) | 1.59725852 |
| 163 | Hyperlipoproteinemia (HP:0010980) | 1.59686919 |
| 164 | Acute myeloid leukemia (HP:0004808) | 1.59685342 |
| 165 | Torticollis (HP:0000473) | 1.59541713 |
| 166 | Urinary urgency (HP:0000012) | 1.59313737 |
| 167 | Downturned corners of mouth (HP:0002714) | 1.59033038 |
| 168 | Right ventricular cardiomyopathy (HP:0011663) | 1.59016879 |
| 169 | Metaphyseal dysplasia (HP:0100255) | 1.58022551 |
| 170 | Hypothermia (HP:0002045) | 1.57932992 |
| 171 | Abnormality of the astrocytes (HP:0100707) | 1.57695952 |
| 172 | Astrocytoma (HP:0009592) | 1.57695952 |
| 173 | Abnormality of the Achilles tendon (HP:0005109) | 1.57591535 |
| 174 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.57515946 |
| 175 | Submucous cleft hard palate (HP:0000176) | 1.57488548 |
| 176 | Lymphangioma (HP:0100764) | 1.57163605 |
| 177 | Glioma (HP:0009733) | 1.56658549 |
| 178 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.54874808 |
| 179 | Pulmonic stenosis (HP:0001642) | 1.54293725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 2.89839728 |
| 2 | MAP3K9 | 2.66279778 |
| 3 | ACVR1B | 2.60266695 |
| 4 | STK38L | 2.41710156 |
| 5 | FRK | 2.21956452 |
| 6 | NTRK3 | 2.13074928 |
| 7 | KSR2 | 2.04599206 |
| 8 | ERBB3 | 2.03927029 |
| 9 | CAMK1G | 1.93756450 |
| 10 | EPHA4 | 1.87969498 |
| 11 | MAP3K2 | 1.82287977 |
| 12 | MAP3K4 | 1.75955528 |
| 13 | BRD4 | 1.75462657 |
| 14 | STK39 | 1.74092337 |
| 15 | CASK | 1.73179642 |
| 16 | RIPK4 | 1.71382523 |
| 17 | NTRK1 | 1.65606596 |
| 18 | CAMKK1 | 1.63894117 |
| 19 | DAPK2 | 1.62774549 |
| 20 | TRIB3 | 1.61956964 |
| 21 | RIPK1 | 1.60566508 |
| 22 | CAMK1D | 1.59922577 |
| 23 | TTN | 1.57889227 |
| 24 | PAK6 | 1.57162769 |
| 25 | PIK3CA | 1.56311941 |
| 26 | PHKG2 | 1.55354195 |
| 27 | PHKG1 | 1.55354195 |
| 28 | NLK | 1.53865792 |
| 29 | TRIM28 | 1.52960751 |
| 30 | BRSK2 | 1.52904553 |
| 31 | LMTK2 | 1.52857642 |
| 32 | BMPR1B | 1.44198972 |
| 33 | PAK3 | 1.42329403 |
| 34 | PNCK | 1.42320126 |
| 35 | OXSR1 | 1.41207315 |
| 36 | TNIK | 1.37899053 |
| 37 | SCYL2 | 1.37885940 |
| 38 | MAP2K4 | 1.36988082 |
| 39 | CAMKK2 | 1.35941774 |
| 40 | TGFBR2 | 1.32856819 |
| 41 | STK3 | 1.32775581 |
| 42 | TRPM7 | 1.30358132 |
| 43 | PDK3 | 1.30356284 |
| 44 | PDK4 | 1.30356284 |
| 45 | MARK1 | 1.30158969 |
| 46 | DMPK | 1.29388351 |
| 47 | WNK1 | 1.25704216 |
| 48 | FGFR2 | 1.24658155 |
| 49 | MKNK2 | 1.24332110 |
| 50 | KSR1 | 1.23117785 |
| 51 | EPHA3 | 1.22000731 |
| 52 | WNK4 | 1.21932555 |
| 53 | INSRR | 1.20215982 |
| 54 | LATS1 | 1.19436560 |
| 55 | FER | 1.18823630 |
| 56 | NEK9 | 1.17394759 |
| 57 | NUAK1 | 1.17248850 |
| 58 | YES1 | 1.17032416 |
| 59 | RET | 1.17016438 |
| 60 | ERN1 | 1.17004733 |
| 61 | NEK6 | 1.16391102 |
| 62 | MINK1 | 1.16340498 |
| 63 | SGK3 | 1.15540548 |
| 64 | SIK1 | 1.15368804 |
| 65 | PRKD3 | 1.13980690 |
| 66 | PTK6 | 1.13677627 |
| 67 | PDPK1 | 1.11881159 |
| 68 | PDK1 | 1.11165091 |
| 69 | WNK3 | 1.06284995 |
| 70 | EIF2AK3 | 1.04779660 |
| 71 | PDGFRA | 1.03961884 |
| 72 | PKN2 | 1.02554030 |
| 73 | JAK1 | 1.02159083 |
| 74 | PRKCH | 1.01469285 |
| 75 | SGK2 | 1.00599275 |
| 76 | PLK4 | 0.98439735 |
| 77 | BCR | 0.95947377 |
| 78 | SGK223 | 0.95467250 |
| 79 | SGK494 | 0.95467250 |
| 80 | MAP3K13 | 0.95419124 |
| 81 | TAOK3 | 0.93970297 |
| 82 | MST4 | 0.93894290 |
| 83 | PDK2 | 0.91632973 |
| 84 | STK38 | 0.90477284 |
| 85 | PINK1 | 0.90435800 |
| 86 | MAP3K7 | 0.88642603 |
| 87 | CDK5 | 0.86069389 |
| 88 | STK24 | 0.84752173 |
| 89 | MAPK13 | 0.83847976 |
| 90 | IRAK1 | 0.82478410 |
| 91 | FGFR1 | 0.79560699 |
| 92 | PDGFRB | 0.76368391 |
| 93 | EPHB1 | 0.76091724 |
| 94 | STK11 | 0.74488919 |
| 95 | PLK2 | 0.72267925 |
| 96 | TYRO3 | 0.72254655 |
| 97 | PTK2 | 0.72219626 |
| 98 | OBSCN | 0.70545073 |
| 99 | CSNK1G2 | 0.70143017 |
| 100 | MELK | 0.69063182 |
| 101 | PTK2B | 0.68825217 |
| 102 | SGK1 | 0.67189969 |
| 103 | FES | 0.64711275 |
| 104 | BLK | 0.62411628 |
| 105 | MAP2K7 | 0.61740583 |
| 106 | PKN1 | 0.61440857 |
| 107 | MAP3K12 | 0.61252867 |
| 108 | DDR2 | 0.60983604 |
| 109 | JAK2 | 0.60500133 |
| 110 | MAP4K2 | 0.59789372 |
| 111 | PIK3CG | 0.59685025 |
| 112 | PRKAA2 | 0.58583036 |
| 113 | FGFR3 | 0.56519652 |
| 114 | PRKD1 | 0.54653006 |
| 115 | MAP2K1 | 0.54425756 |
| 116 | BMPR2 | 0.53916551 |
| 117 | FYN | 0.53795589 |
| 118 | CAMK2A | 0.52426055 |
| 119 | TAOK1 | 0.52113660 |
| 120 | MST1R | 0.51776218 |
| 121 | PRKAA1 | 0.51583744 |
| 122 | CAMK2D | 0.51183722 |
| 123 | ROCK1 | 0.50875282 |
| 124 | PRKCE | 0.49781825 |
| 125 | MAPK12 | 0.49580700 |
| 126 | PRKCG | 0.49435932 |
| 127 | CSNK1G1 | 0.48373503 |
| 128 | MET | 0.47726431 |
| 129 | ERBB2 | 0.47639073 |
| 130 | CSNK1A1L | 0.47413601 |
| 131 | PRKCQ | 0.46842594 |
| 132 | ERBB4 | 0.46358571 |
| 133 | MKNK1 | 0.44750028 |
| 134 | MAP3K1 | 0.44653507 |
| 135 | PBK | 0.43724784 |
| 136 | CAMK2G | 0.42632543 |
| 137 | CAMK2B | 0.41920545 |
| 138 | CAMK4 | 0.41754628 |
| 139 | CAMK1 | 0.41191951 |
| 140 | RPS6KB1 | 0.41078572 |
| 141 | EGFR | 0.34927642 |
| 142 | PRKACB | 0.33944048 |
| 143 | PRKG1 | 0.33587610 |
| 144 | MYLK | 0.30589121 |
| 145 | FGR | 0.30155264 |
| 146 | ATM | 0.27683371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.05518522 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 2.07013731 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63885954 |
| 4 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.56115452 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 1.49205326 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45805113 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41720955 |
| 8 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41092344 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 1.40384684 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.39742106 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.34434290 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.32607751 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30166998 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.30130389 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.27319297 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.24768674 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.24440292 |
| 18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.21633423 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20518099 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.20253744 |
| 21 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.20012408 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18215768 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.17656462 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17540188 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16239240 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15814233 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14547055 |
| 28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.12153731 |
| 29 | Lysine degradation_Homo sapiens_hsa00310 | 1.11739178 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.09897782 |
| 31 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.09109975 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08669276 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.08356052 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.08308426 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.06243257 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05141981 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.01883708 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00255698 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00143422 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.99857415 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 0.99480743 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98518939 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.98430991 |
| 44 | Morphine addiction_Homo sapiens_hsa05032 | 0.96522670 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96089989 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.95910604 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94743437 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94622074 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94043534 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92247292 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.92155680 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91970159 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.91627954 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91399225 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90104589 |
| 56 | Prostate cancer_Homo sapiens_hsa05215 | 0.89765772 |
| 57 | Long-term depression_Homo sapiens_hsa04730 | 0.89534609 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.88738483 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86235249 |
| 60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85795952 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85561299 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85221470 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84909102 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83695187 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82318365 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81128628 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.81032933 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80844922 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80214983 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79753224 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79383985 |
| 72 | Melanoma_Homo sapiens_hsa05218 | 0.79054338 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78392714 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78302475 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78197199 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78129838 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78057514 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.77402088 |
| 79 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.76569370 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76516549 |
| 81 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.76389045 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74847999 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74263737 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74237454 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72270034 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71688686 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71610082 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70806595 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70309852 |
| 90 | Gap junction_Homo sapiens_hsa04540 | 0.69227948 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68981235 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68631146 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.67243338 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65829142 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65261681 |
| 96 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64869761 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64614284 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64135760 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64101571 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.61603288 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.61288971 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.61153875 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.60723562 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60445083 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60346765 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59874741 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59256101 |
| 108 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58212099 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58148547 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57828295 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.57711920 |
| 112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.57434894 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56266057 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.55611823 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55466622 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.55100636 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54362449 |
| 118 | Taste transduction_Homo sapiens_hsa04742 | 0.54234243 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53715735 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53517032 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53337043 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53174574 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52556132 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51986934 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51681602 |
| 126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51483375 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50174018 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50147897 |
| 129 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49680146 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.48367415 |
| 131 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48097302 |
| 132 | Platelet activation_Homo sapiens_hsa04611 | 0.47528821 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47362702 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46257303 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45327345 |
| 136 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45111513 |

